These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 10428734

  • 41. Insulin-metformin combination therapy in obese patients with type 2 diabetes.
    Jaber LA, Nowak SN, Slaughter RR.
    J Clin Pharmacol; 2002 Jan; 42(1):89-94. PubMed ID: 11808829
    [Abstract] [Full Text] [Related]

  • 42. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
    Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709
    [Abstract] [Full Text] [Related]

  • 43. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
    Baradari AG, Emami Zeydi A, Aarabi M, Ghafari R.
    Pak J Biol Sci; 2011 Dec 01; 14(23):1047-54. PubMed ID: 22590838
    [Abstract] [Full Text] [Related]

  • 44. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.
    Lee A, Morley JE.
    Obes Res; 1998 Jan 01; 6(1):47-53. PubMed ID: 9526970
    [Abstract] [Full Text] [Related]

  • 45. Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes.
    Heise T, Morrow L, Hompesch M, Häring HU, Kapitza C, Abt M, Ramsauer M, Magnone MC, Fuerst-Recktenwald S.
    Diabetes Obes Metab; 2014 Nov 01; 16(11):1070-7. PubMed ID: 24828020
    [Abstract] [Full Text] [Related]

  • 46. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.
    Uehara MH, Kohlmann NE, Zanella MT, Ferreira SR.
    Diabetes Obes Metab; 2001 Oct 01; 3(5):319-25. PubMed ID: 11703421
    [Abstract] [Full Text] [Related]

  • 47. Effect of metformin glycinate on glycated hemoglobin A1C concentration and insulin sensitivity in drug-naive adult patients with type 2 diabetes mellitus.
    González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Ramos-Zavala MG, Barrera-Durán C, González-Canudas J.
    Diabetes Technol Ther; 2012 Dec 01; 14(12):1140-4. PubMed ID: 22974412
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Improved glycemic control without weight gain using triple therapy in type 2 diabetes.
    Strowig SM, Avilés-Santa ML, Raskin P.
    Diabetes Care; 2004 Jul 01; 27(7):1577-83. PubMed ID: 15220231
    [Abstract] [Full Text] [Related]

  • 50. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
    Aghasi M, Koohdani F, Qorbani M, Nasli-Esfahani E, Ghazi-Zahedi S, Khoshamal H, Keshavarz A, Sotoudeh G.
    J Sci Food Agric; 2019 Jun 01; 99(8):3933-3940. PubMed ID: 30701554
    [Abstract] [Full Text] [Related]

  • 51. The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients.
    Meyer L, Bohme P, Delbachian I, Lehert P, Cugnardey N, Drouin P, Guerci B.
    Diabetes Care; 2002 Dec 01; 25(12):2153-8. PubMed ID: 12453953
    [Abstract] [Full Text] [Related]

  • 52. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
    Mäkimattila S, Nikkilä K, Yki-Järvinen H.
    Diabetologia; 1999 Apr 01; 42(4):406-12. PubMed ID: 10230643
    [Abstract] [Full Text] [Related]

  • 53. A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes.
    Wang CY, Huang KC, Lu CW, Chu CH, Huang CN, Chen HS, Lee IT, Chen JF, Chen CC, Chen CS, Hsieh CH, Tien KJ, Chien HY, Huang YY, Hsu JP, Shane GT, Chang AC, Wu YC, Sheu WH.
    J Clin Endocrinol Metab; 2022 Sep 28; 107(10):e4063-e4071. PubMed ID: 35917580
    [Abstract] [Full Text] [Related]

  • 54. The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.
    Zhang F, Xiang H, Fan Y, Ganchuluun TA, Kong W, Ouyang Q, Sun J, Cao B, Jiang H, Nie S.
    Endocrine; 2013 Dec 28; 44(3):648-58. PubMed ID: 23657947
    [Abstract] [Full Text] [Related]

  • 55. The effects of metformin in type 1 diabetes mellitus.
    Beysel S, Unsal IO, Kizilgul M, Caliskan M, Ucan B, Cakal E.
    BMC Endocr Disord; 2018 Jan 16; 18(1):1. PubMed ID: 29338714
    [Abstract] [Full Text] [Related]

  • 56. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.
    Särnblad S, Kroon M, Aman J.
    Eur J Endocrinol; 2003 Oct 16; 149(4):323-9. PubMed ID: 14514347
    [Abstract] [Full Text] [Related]

  • 57. Double-blind evaluation of efficacy and tolerability of metformin in NIDDM.
    Dornan TL, Heller SR, Peck GM, Tattersall RB.
    Diabetes Care; 1991 Apr 16; 14(4):342-4. PubMed ID: 2060439
    [Abstract] [Full Text] [Related]

  • 58. [Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment].
    Boronat Cortés M, Marrero Arencibia D, La Roche Brier F, Ojeda Pino A, Carrillo Domínguez A, Nóvoa Mogollón FJ.
    Rev Clin Esp; 2000 Feb 16; 200(2):74-6. PubMed ID: 10776038
    [Abstract] [Full Text] [Related]

  • 59. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
    Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.
    Ann Intern Med; 2007 Sep 18; 147(6):386-99. PubMed ID: 17638715
    [Abstract] [Full Text] [Related]

  • 60. Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.
    Top W, Stehouwer C, Lehert P, Kooy A.
    Diabetes Obes Metab; 2018 Mar 18; 20(3):730-733. PubMed ID: 28967181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.